Bioceres Crop Solutions Corp.

NasdaqGS:BIOX 株式レポート

時価総額:US$696.3m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Bioceres Crop Solutions 過去の業績

過去 基準チェック /26

Bioceres Crop Solutionsは、平均年間56.3%の収益成長を遂げていますが、 Chemicals業界の収益は、年間 成長しています。収益は、平均年間14.4% 25.7%収益成長率で 成長しています。 Bioceres Crop Solutionsの自己資本利益率は1.6%であり、純利益率は0.7%です。

主要情報

56.3%

収益成長率

60.6%

EPS成長率

Chemicals 業界の成長12.9%
収益成長率25.7%
株主資本利益率1.6%
ネット・マージン0.7%
前回の決算情報31 Mar 2024

最近の業績更新

Recent updates

Bioceres Needs To Add Clarity Around Borrowings

Mar 23

Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt

Feb 03
Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Oct 04
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear

Jun 21
Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear

Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load

May 09
Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load

Bioceres: A Resilient Small Cap With Conference Appearances After Thursday's Earnings

Sep 06

Bioceres Crop Solutions jumps 15% after investor pitch

Aug 23

We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Apr 10
We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Bioceres Has Not Resolved Its Major Risks And Is Growing Based On Commodities Bullishness

Mar 31

Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Mar 17
Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Nov 13
Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Jul 08
Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Jun 16
Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

May 26
What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

Bioceres partners with Havanna to offer consumers HB4 wheat-based sustainable products

May 10

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

May 05
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Apr 05
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Mar 10
Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

Feb 12
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

収支内訳

Bioceres Crop Solutions の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NasdaqGS:BIOX 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
31 Mar 24446310616
31 Dec 234552210416
30 Sep 234091410216
30 Jun 23419199915
31 Mar 23416159513
31 Dec 22391-198811
30 Sep 22389-8789
30 Jun 22328-7657
31 Mar 22308-2587
31 Dec 212754526
30 Sep 212311466
30 Jun 21207-7456
31 Mar 21174-5374
31 Dec 20164-7354
30 Sep 201783344
30 Jun 201723334
31 Mar 201740365
31 Dec 19167-18365
30 Sep 19167-23364
30 Jun 19160-18344
31 Mar 19142-26293
31 Dec 18145-8283
30 Sep 18129-13294
30 Jun 18133-11314
30 Jun 1794-12274
31 Dec 1641-681
31 Dec 155-110

質の高い収益: BIOXは 高品質の収益 を持っています。

利益率の向上: BIOXの現在の純利益率 (0.7%)は、昨年(3.7%)よりも低くなっています。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: BIOX過去 5 年間で収益を上げており、収益は年間56.3%増加しています。

成長の加速: BIOXは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。

収益対業界: BIOXは過去 1 年間で収益成長率がマイナス ( -80.2% ) となったため、 Chemicals業界平均 ( -24.2% ) と比較することが困難です。


株主資本利益率

高いROE: BIOXの 自己資本利益率 ( 1.6% ) は 低い とみなされます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘